RATIONALE OF THROMBOLYTIC THERAPY IN ARTERIAL OCCLUSIVE DISEASE.
D000925:Anticoagulants; D001157:Arterial Occlusive Diseases; D003327:Coronary Disease; D003850:Deoxyribonuclease I; D004358:Drug Therapy; D004617:Embolism; D005342:Fibrinolysis; D013299:Streptodornase and Streptokinase; D013300:Streptokinase; D013917:Thrombin; D015912:Thrombolytic Therapy; D013927:Thrombosis
D000925:Anticoagulants; D013299:Streptodornase and Streptokinase; D003850:Deoxyribonuclease I; D013300:Streptokinase; D013917:Thrombin
ANTICOAGULANTS; CORONARY DISEASE; DRUG THERAPY; EMBOLISM; FIBRINOLYSIS; STREPTODORNASE AND STREPTOKINASE; THROMBIN; THROMBOSIS